Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

A team of Israeli researchers has identified how the structure and chemical changes in the DNA influence the risk of ...

The U.S. Department of Defense’s premier Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) Command selected a ...

A team from the University of Washington led by Nobel laureate David Baker is using artificial intelligence to design ...

The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...

The study from The Hebrew University of Jerusalem, led by Prof. Sheera Adar and her graduate student Elisheva Heilbrun-Katz ...

Unfortunately, there isn't an enzyme for many reactions we would sorely like to catalyze—things like digesting plastics or ...

A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: a shuttling mechanism that helps a complex of proteins pump out a wide ...

Prof. Dan Shechtman of the Technion–Israel Institute of Technology made the discovery that would later earn him the 2011 ...

Enzymes significantly speed up the chemical reactions that keep you alive. Researchers are using AI to create new ones to tackle modern challenges.

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

Chemists in Arts & Sciences at Washington University in St. Louis have received a $1 million contract from the Defense Threat ...